Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
Fecal microbiota transplantation in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial
粪便微生物群移植联合免疫检查点阻断治疗晚期黑色素瘤患者：一项随机 II 期试验
批准号：
490062
负责人：
Dancey Janet E
金额：
$130.13万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer immunotherapy (IO) enables immune cells to recognize and kill melanoma cells improving the lives of patients. While IO is now the standard-of-care to treat melanoma, melanoma remains the leading cause of skin cancer-related death in Canada, and mos
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Melanoma Margins Trial II - A Phase III, Multi-centre Randomized Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC stage II Primary Cutaneous Melanoma (MelMarT-II)
-
批准号：408863
-
项目类别：Operating Grants
-
资助金额：$94.96万
-
财政年份：2019
-
负责人：Dancey Janet E
-
依托单位：
海外基金
